Skip to main content
SpringerLink
Log in

Journal Watch

  • Update
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Reference

  • Dingemanse J, Appel-Dingemanse S. Integrated pharmacokinetics and pharmacodynamics in drug development. Clin Pharmacokinet 2007; 46 (9): 713–37

    Article  PubMed  CAS  Google Scholar 

Reference

  • Hughes D. When drugs don’t work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007; 25 (8): 621–35

    Article  PubMed  Google Scholar 

Reference

  • Hauben M, Aronson JK. Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. Drug Saf 2007; 30 (8): 645–55

    Article  PubMed  Google Scholar 

Reference

  • Honer WG, Thornton AE, Sherwood M, et al. Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. CNS Drugs 2007; 21 (9): 699–714

    Article  PubMed  CAS  Google Scholar 

Reference

  • Licata AA. Clinical perspectives on bone quality in osteoporosis: effects of drug therapy. Drugs Aging 2007; 24 (7): 529–35

    Article  PubMed  CAS  Google Scholar 

Reference

  • Shi L, Wu EQ, Hodges M, et al. Retrospective economic and outcomes analyses using non-us databases: a review. Pharmacoeconomics 2007; 25 (7): 563–576

    Article  PubMed  Google Scholar 

Reference

  • Booth BA, Vidal Denham L, Bouhanik S, et al. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications. Drugs Aging 2007; 24 (7): 581–602

    Article  PubMed  CAS  Google Scholar 

Reference

Reference

Reference

  • Skrepnek GH. The contrast and convergence of bayesian and frequentist statistical approaches in pharmacoeconomic analysis. Pharmacoeconomics 2007; 25 (8): 649–64

    Article  PubMed  Google Scholar 

Reference

  • Khuseyinova N, Koenig W. Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A2 fit in? Mol Diagn Ther 2007; 11 (4): 203–17

    Article  PubMed  CAS  Google Scholar 

Reference

  • Lavi S, Lavi R, McConnell JP, et al. Lipoprotein-associated phospholipase A2: review of its role as a marker and a potential participant in coronary endothelial dysfunction. Mol Diagn Ther 2007; 11 (4): 219–26

    Article  PubMed  CAS  Google Scholar 

Reference

  • Nakamura K, Rockson SG. Biomarkers of Lymphatic Function and Disease: State of the Art and Future Directions. Mol Diagn Ther 2007; 11 (4): 227–38

    Article  PubMed  CAS  Google Scholar 

Reference

  • Avner M, Finkelstein Y, Hackam D. Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale. Pediatr Drugs 2007; 9 (4): 267–70

    Article  Google Scholar 

Reference

  • Bao F, Munker R, Lowery C, et al. Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias. Mol Diagn Ther 2007; 11 (4): 239–45

    Article  PubMed  CAS  Google Scholar 

Reference

  • Lamers LM, Uyl-de Groot CA, Buijt I. The use of disease-specific outcome measures in cost-utility analysis: the development of dutch societal preference weights for the FACTL scale. Pharmacoeconomics 2007; 25 (7): 591–603

    Article  PubMed  Google Scholar 

Reference

  • Tappenden P, Brazier J, Ratcliffe J, et al. A stated preference binary choice experiment to explore NICE decision making. Pharmacoeconomics 2007; 25 (8): 685–93

    Article  PubMed  Google Scholar 

Reference

  • Matsushita Y, Kuroda Y, Niwa S, et al. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Drug Saf 2007; 30 (8): 715–26

    Article  PubMed  Google Scholar 

Reference

  • Dore DD, DiBello JR, Lapane KL. Telithromycin use and spontaneous reports of hepatotoxicity. Drug Saf 2007; 30 (8): 697–703

    Article  PubMed  Google Scholar 

Reference

  • Yang TY. The simple classification of multiple cancer types using a small number of significant genes. Mol Diagn Ther 2007; 11 (4): 265–75

    Article  PubMed  CAS  Google Scholar 

Reference

  • van der Velde N, Stricker BHC, Pols HAP, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24 (8): 691–9

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Watch. Int J Pharm Med 21, 373–380 (2007). https://doi.org/10.2165/00124363-200721050-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00124363-200721050-00009

Keywords

Search

Navigation